NCT05650671 (MECMISA) is a clinical trial of instrumented wheelchair in Wheelchair Users, sponsored by Université de Reims Champagne-Ardenne.

Who is sponsoring NCT05650671?

NCT05650671 is sponsored by Université de Reims Champagne-Ardenne.

What drugs are being tested in NCT05650671?

Interventions in NCT05650671: instrumented wheelchair.

What condition does NCT05650671 study?

NCT05650671 studies Wheelchair Users.

Is NCT05650671 still recruiting?

NCT05650671 is currently status unknown. Last updated 14 December 2022.

Last reviewed 2022-12-14 · How we verify

NCT05650671: MECMISA

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Measurement of Multiphysical Fields at the Subject-sitting Interface

Status unknown Last updated 14 December 2022

What this trial tests

trial testing instrumented wheelchair in Wheelchair Users in 90 participants. Status unknown.

Timeline

1 March 2023

Primary endpoint
1 April 2023

1 July 2023

Quick facts

Lead sponsor	Université de Reims Champagne-Ardenne
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	90
Start date	1 March 2023
Primary completion	1 April 2023
Estimated completion	1 July 2023

Drugs / interventions tested

instrumented wheelchair

Conditions studied

Wheelchair Users — all drugs for Wheelchair Users →

Sponsor

Université de Reims Champagne-Ardenne

Who can join

18 and older, any sex, with Wheelchair Users. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

With the population ageing and the increase in disabilities prevalence, demand for wheelchairs is increasing. Padding and shape of seat are important factors for comfort when sitting for long periods of time. Sustained mechanical loads induced by the seated stance can cause pressure ulcers in the ischial prominences. Temperature and humidity have also been shown to be important in the development of pressure ulcers.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Université de Reims Champagne-Ardenne trials

Trials by the same sponsor.

NCT07437495 — Women's Knowledge of Contraception During the Postpartum Period · active not recruiting
NCT07418359 — Comparison of Patient's Physical Activity Levels According to the Physical Activity Level of Their General Practitioner · recruiting
NCT07424937 — Prevalence of Regular Gynecological Follow-up Among Women of Childbearing Age · completed
NCT07440082 — Resumption of Sexual Intercourse in the Postpartum Period: Women's Experiences · completed
NCT07241299 — Understanding Chronic Treatments by Patients Over 65 Years of Age · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05650671 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Université de Reims Champagne-Ardenne
Last refreshed: 14 December 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05650671.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing